Further studies are also needed to perform meSDC2 LTE-qMSP test using stool DNA samples from patients with inflammatory bowel disease (IBD) to determine the potential influence of exfoliation of methylated SDC2 DNA from small neoplasms in IBD on test results. The gene discussed is SDC2; the disease is neoplasm.